A Tannapfel
Overview
Explore the profile of A Tannapfel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
265
Citations
2479
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Starosta A, Ehler J, Loffler B, Tannapfel A, Zipprich A, Reuken P, et al.
Infection
. 2025 Feb;
PMID: 39907911
Background: Enterovirus infection has been described as a cause of severe viral sepsis in humorally immunosuppressed patients. Case Presentation: A 20-year-old female with a history of multiple sclerosis on ocrelizumab...
2.
Alig A, Modest D, Stintzing S, Heinrich K, Geissler M, Fischer von Weikersthal L, et al.
ESMO Open
. 2024 Aug;
9(9):103677.
PMID: 39173562
Background: Primary tumor (PT) sidedness is an established prognostic marker in metastatic colorectal cancer (mCRC) and has a predictive impact on the efficacy of anti-epidermal growth factor receptor (anti-EGFR) antibody...
3.
Krentel H, Naem A, Tannapfel A, Devassy R, Constantin A, De Wilde R
Facts Views Vis Obgyn
. 2023 Dec;
15(4):325-329.
PMID: 38128090
Background: Endometriosis is a chronic inflammatory oestrogen-dependent disease. It is characterised by elevated inflammatory markers in the peritoneal milieu with subsequent adhesiogenesis. Nowadays, excisional, and ablative surgeries are considered the...
4.
Seufferlein T, Uhl W, Kornmann M, Algul H, Friess H, Konig A, et al.
Ann Oncol
. 2022 Oct;
34(1):91-100.
PMID: 36209981
Background: Data on perioperative chemotherapy in resectable pancreatic ductal adenocarcinoma (rPDAC) are limited. NEONAX examined perioperative or adjuvant chemotherapy with gemcitabine plus nab-paclitaxel in rPDAC (National Comprehensive Cancer Network criteria)....
5.
Roeb E, Canbay A, Bantel H, Bojunga J, de Laffolie J, Demir M, et al.
Z Gastroenterol
. 2022 Sep;
60(9):1346-1421.
PMID: 36100202
No abstract available.
6.
Bitzer M, Voesch S, Albert J, Bartenstein P, Bechstein W, Blodt S, et al.
Z Gastroenterol
. 2022 Feb;
60(2):219-238.
PMID: 35148562
No abstract available.
7.
Bitzer M, Voesch S, Albert J, Bartenstein P, Bechstein W, Blodt S, et al.
Z Gastroenterol
. 2022 Feb;
60(2):e186-e227.
PMID: 35148560
No abstract available.
8.
Gambichler T, Stricker I, Neid M, Tannapfel A, Susok L
J Eur Acad Dermatol Venereol
. 2022 Feb;
36(6):e490-e492.
PMID: 35143084
No abstract available.
9.
Gambichler T, Krogias C, Tischoff I, Tannapfel A, Gold R, Susok L
Br J Dermatol
. 2021 Nov;
186(2):e83.
PMID: 34726769
No abstract available.
10.
Gambichler T, Boms S, Hessam S, Tischoff I, Tannapfel A, Luttringhaus T, et al.
Br J Dermatol
. 2021 Jul;
185(6):1259-1262.
PMID: 34228815
No abstract available.